Credo Advanced Chemicals Unlisted Share
Credo Advanced Chemicals Ltd.
INE162M01015
Incorporation Date: 23-Jun-1995
Listing Status: DRHP Not Filed
(Earlier Credo Minerals)
About Credo Advanced Chemicals Unlisted Share
Overview of Credo Advanced Chemicals Unlisted Share
Business Overview
- Founded in 1995 and headquartered in Gujarat, India, Credo Advanced Chemicals Limited (CACL), formerly known as Credo Mineral Industries Limited, operates in the mineral exploration and mining industry, specializing in the production and sale of bauxite, iron ore, and limestone.
- Over the years, the company has earned a strong reputation for quality, safety, and sustainability, driven by significant investments in research and development that have enhanced mining and processing efficiency while minimizing environmental impact. As a holding company of the Credo Group, CACL is primarily engaged in the manufacturing of specialty chemicals and mineral-based products, with operations spanning exploration, beneficiation, processing, and the development of chemical and mineral-based industries.
- The company functions through Special Purpose Vehicles (SPVs), including key subsidiaries such as Gujarat Credo Mineral Industries Ltd (GCMIL) and Gujarat Credo Alumina Chemicals Ltd (GCACL), which own and operate world-class manufacturing facilities producing high-quality products for various industrial applications. CACL’s commitment to its core values and operational strength is clearly reflected in its Management Discussion and Analysis Report.
Products
Alumina TriHydrate (ATH)
Alumina TriHydrate (ATH) or Aluminium Hydroxide is a key raw material used in various industries due to its unique reactivity with both acids and bases. Credo Advanced Chemicals Limited is a leading manufacturer and supplier of ATH in Gujarat, India.
Key Products & Applications:
- MH 01 & MH 01D – Used in manufacturing inorganic chemicals such as Non-ferric Alum, Poly Aluminium Chloride, Aluminium Fluoride, Sodium Aluminate, Catalysts, and Glass.
- MH 02 – A specialty alumina hydrate applied in composites, fire retardants, rubber, marble, paper, and paints, available in different particle sizes.
- Synthetic Zeolite 4A (MZ 01) – Used in the detergent industry for producing biodegradable, phosphorus-free detergents with high liquid absorption capacity.
- MZPS 1 – A co-stabilizer in PVC stabilization, reducing thermal decomposition and discoloration while being eco-friendly.
Product Segmentation Revenue -Wise
Geographical Segmentation
General Information:
- Color: White Powder
- Packaging: Available in 50 kg bags, jumbo bags, or bulk delivery
- Safety: Non-hazardous, non-toxic, and non-inflammable
Credo’s strong manufacturing capabilities, innovation, and eco-friendly solutions position it as a key supplier in the chemical, construction, and industrial sectors. Its focus on high-quality production and diverse applications ensures steady demand and growth potential in both domestic and international markets.
Board of Directors
| Name | Designation |
|---|---|
| Shri Anand Patel | Non-Executive Director |
| Shri Rakesh Shah | Whole-Time Director |
| Shri Naman Patel | Managing Director |
Insights of Credo Advanced Chemicals Unlisted Share
CREDO ADVANCED CHEMICALS LTD.
Financial Highlights
CREDO ADVANCED CHEMICALS LTD.
Financial Highlights
All monetary figures are in ₹ crore. FY26 and FY25 figures are based on the consolidated data supplied.
| Particulars | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Net Revenue | 249.23 | 278.67 | -10.56% |
| Total Operating Cost | 174.76 | 189.39 | -7.73% |
| EBITDA | 74.47 | 89.28 | -16.59% |
| EBITDA Margin | 29.88% | 32.03% | -2.15 pp |
| Other Income | 1.50 | 0.65 | +130.77% |
| Depreciation & Amortization | 18.43 | 17.00 | +8.41% |
| EBIT | 57.54 | 72.93 | -21.09% |
| Finance Costs | 21.14 | 31.46 | -32.80% |
| Profit Before Tax | 36.40 | 41.48 | -12.25% |
| Income Tax | 3.10 | 12.20 | -74.59% |
| Profit After Tax | 33.30 | 53.53 | -37.79% |
| PAT Margin | 13.36% | 19.21% | -5.85 pp |
pp = percentage points. Percentage changes are calculated using the supplied figures and rounded to two decimal places.
What the Numbers Tell Us
1. Revenue Declined by 10.56%
Revenue decreased from ₹278.67 crore in FY25 to ₹249.23 crore in FY26, a reduction of ₹29.44 crore.
This indicates that the company generated lower revenue in FY26. The figures alone cannot establish whether the decline resulted from lower sales volumes, pricing pressure, changes in product mix, customer demand, or other factors.
2. Operating Costs Fell More Slowly Than Revenue
Total operating costs declined from ₹189.39 crore to ₹174.76 crore, a reduction of 7.73%. However, revenue fell by 10.56%.
Because costs did not decline as quickly as revenue, operating profitability weakened. This is reflected in the EBITDA margin, which fell from 32.03% to 29.88%.
3. EBITDA Declined by 16.59%
EBITDA decreased from ₹89.28 crore in FY25 to ₹74.47 crore in FY26, a reduction of ₹14.81 crore.
The decline in EBITDA was greater than the decline in revenue, suggesting that the company faced pressure on its operating earnings. Nevertheless, the FY26 EBITDA margin of 29.88% indicates that the company continued to generate a positive operating surplus.
4. Finance Costs Reduced Significantly
Finance costs decreased from ₹31.46 crore to ₹21.14 crore, a decline of 32.80%.
This is a positive development because lower finance costs reduce the amount of operating earnings consumed by interest and other financing charges. The reduction helped cushion the impact of weaker EBIT on profit before tax.
However, the supplied figures do not establish whether this reduction resulted from lower borrowings, lower interest rates, repayment of debt, or another factor.
5. Net Profit Fell by 37.79%
PAT declined from ₹53.53 crore in FY25 to ₹33.30 crore in FY26, a decrease of ₹20.23 crore.
The PAT margin contracted from 19.21% to 13.36%. Therefore, the company retained positive profitability but converted a smaller proportion of revenue into net profit.
The decline in PAT was greater than the decline in revenue, making profitability a key area to monitor.
6. Lower Tax Expense Supported Earnings
Income tax expense decreased from ₹12.20 crore in FY25 to ₹3.10 crore in FY26.
The lower tax expense partly offset the decline in operating earnings. However, the supplied figures do not explain whether this resulted from changes in taxable profit, deferred tax, tax adjustments, or other items. The effective tax rate also fell substantially, from approximately 29.41% to 8.52%, and warrants verification against the annual report.
Key Investor Observations
1. Revenue and Profitability Are Moving Downward
Both revenue and EBITDA declined in FY26. The simultaneous reduction in revenue and EBITDA margin suggests that the company experienced pressure on its operating performance, rather than a decline in sales alone.
2. Operating Margins Remain Positive
Despite the decline, the company reported an EBITDA margin of 29.88% and a PAT margin of 13.36% in FY26. These figures indicate continued profitability, although the direction of change deserves attention.
3. Lower Finance Costs Are a Positive Factor
The 32.80% reduction in finance costs helped support profit before tax. Investors should check the balance sheet, borrowings, and cash-flow statement to understand whether this reduction reflects sustainable deleveraging or a temporary change.
4. Depreciation Increased While EBIT Declined
Depreciation and amortization rose from ₹17.00 crore to ₹18.43 crore, while EBIT fell from ₹72.93 crore to ₹57.54 crore. This combination contributed to weaker earnings before financing costs and tax.
The figures do not establish whether the increase in depreciation relates to new capital expenditure, asset additions, or changes in the asset base.
5. The Lower Tax Charge Requires Context
The effective tax rate of approximately 8.52% in FY26 is materially below the FY25 rate of approximately 29.41%. As a result, the reduction in PAT was less severe than it might have been under an unchanged tax rate. Investors should review the tax reconciliation in the annual report before treating this lower rate as sustainable.
6. No Exceptional or Associate-Related Effects Were Reported in the Supplied Data
The supplied statement records exceptional items of ₹0.00 crore in both years and no minority-interest or associate/joint-venture adjustment. On that basis, the reported PAT equals profit from continuing operations in both periods.
These classifications should still be checked against the original consolidated financial statements.
Key Takeaways
Revenue: Declined by 10.56% to ₹249.23 crore.
EBITDA: Declined by 16.59% to ₹74.47 crore.
EBITDA margin: Contracted by 2.15 percentage points to 29.88%.
Finance costs: Fell by 32.80% to ₹21.14 crore, providing support to earnings.
PAT: Declined by 37.79% to ₹33.30 crore.
PAT margin: Fell by 5.85 percentage points to 13.36%.
Taxation: The effective tax rate dropped materially and should be investigated.
Overall Assessment
Credo Advanced Chemicals Ltd. remained profitable in FY26, but its financial performance weakened compared with FY25. Lower revenue, a sharper decline in EBITDA, higher depreciation, and reduced net profit are the principal concerns. The substantial reduction in finance costs is encouraging, but the sharp fall in the effective tax rate also influenced the reported earnings outcome.
Financial Charts of Credo Advanced Chemicals Unlisted Share
Balance Sheet of Credo Advanced Chemicals Unlisted Share
Profit and Loss of Credo Advanced Chemicals Unlisted Share
Ancillary of Credo Advanced Chemicals Unlisted Share
Ratio Analysis
Peers
Industry Benchmarking
Segment Revenue
Subsidaries
Security Allotment
Corporate Governance
Team Management Details
FAQs of Credo Advanced Chemicals Unlisted Share
-
How to buy CREDO ADVANCED CHEMICALS LTD?
Below are three ways through which you can purchase CREDO ADVANCED CHEMICALS LTD:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to buy CREDO ADVANCED CHEMICALS LTD, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
How to sell CREDO ADVANCED CHEMICALS LTD?
Below are three ways through which you can sell CREDO ADVANCED CHEMICALS LTD:
- We at Altius Investech have many actively traded scripts and are market makers of unlisted shares. To check out all the unlisted shares traded. (Click on link). To submit a request to sell CREDO ADVANCED CHEMICALS LTD, please click on the trade button at the top of this page
- Additionally, you can download our app from your play store or app store, register on our application, and engage in active trading there.
Download the Altius App here https://onelink.to/hf4m72 - You can also reach out to us at : +91 8240614850 / +91 8240861716
-
What is the price of CREDO ADVANCED CHEMICALS LTD?
We provide a two way quote on all the shares we deal in. Your buy price for CREDO ADVANCED CHEMICALS LTD is ₹56 and your sell price for CREDO ADVANCED CHEMICALS LTD is ₹35. The price is based on our estimates and market conditions.
-
What is the lock-in period of CREDO ADVANCED CHEMICALS LTD?
The lock-in period for CREDO ADVANCED CHEMICALS LTD varies depending on the category of investors:
- For retail Investors, HNIs, or Body Corporates, the lock-in period is 6 months from the date of the listing of CREDO ADVANCED CHEMICALS LTD
- For Venture Capital Funds or Foreign Venture Capital Investors, there is a lock-in period of 6 months from the date of acquisition of CREDO ADVANCED CHEMICALS LTD
- For AIF-II (Alternative Investment Funds - Category II), there is no lock-in period
August 2021 saw the introduction of this regulation by SEBI. The purpose of the regulation change, which lowered the lock-in period from a year to six months, was to incentivize additional investments in firms getting ready for initial public offerings, or IPOs. Since its introduction, a number of Portfolio Management Services (PMS) have advised their clients to purchase Pre-IPO shares in order to take advantage of the advantages associated with early-stage investments. This reduction in the lock-in period is considered as a significant step forward.
-
How is the CREDO ADVANCED CHEMICALS LTD price calculated?
Fundamental & Comparative valuation models and the forces of demand and supply in the market for unlisted shares dictate the price. These prices are based on our estimates and transaction history of CREDO ADVANCED CHEMICALS LTD. The price is also determined from the most recent funding round for CREDO ADVANCED CHEMICALS LTD. This provides us with a benchmark valuation, offering a clear indication of the company's current market value as perceived by investors and industry experts.
-
What are the lot sizes of CREDO ADVANCED CHEMICALS LTD?
We can generally arrange lot sizes starting with an investment of INR 20,000. To confirm the lot sizes of CREDO ADVANCED CHEMICALS LTD with us kindly click here.
-
What are the financials of CREDO ADVANCED CHEMICALS LTD?
The financials of CREDO ADVANCED CHEMICALS LTD which includes the P/L of CREDO ADVANCED CHEMICALS LTD and the Balance Sheet of CREDO ADVANCED CHEMICALS LTD is in the financials section (Click on link).
-
Where can I find the annual report of CREDO ADVANCED CHEMICALS LTD?
The annual report of CREDO ADVANCED CHEMICALS LTD is available in the annual report section (Click on link).
-
Is buying CREDO ADVANCED CHEMICALS LTD legal in India?
Yes, buying and selling unlisted shares in India is indeed 100% legal. This activity is regulated and governed under the guidelines provided by the Securities and Exchange Board of India (SEBI). Investors and traders must adhere to these regulations and guidelines to ensure compliance with legal and financial standards. It's important for participants in the unlisted share market to be aware of and understand these regulations to engage in transactions legally and securely.
-
Short-term Capital Gain taxes to be paid on CREDO ADVANCED CHEMICALS LTD?
When you sell unlisted shares within a period of two years from the date of acquisition, any profit earned from the sale is classified as Short-term Capital Gain (STCG). This gain is then added to your total income for that financial year. The tax on this short-term capital gain is calculated based on your applicable individual income tax slab rates. Therefore, the rate at which you will pay tax on the STCG from unlisted shares depends on your total income, including this gain, and the tax slab it falls under as per the prevailing income tax laws in India. It's important for investors to consider these tax implications when engaging in transactions involving unlisted shares.
-
Long-term Capital Gain taxes to be paid on CREDO ADVANCED CHEMICALS LTD and how are They Taxed?
Long-term Capital Gains (LTCG) on unlisted shares in India refer to the profits earned from the sale of unlisted shares that have been held for more than two years. The key aspects of LTCG on unlisted shares include:
- Tax Rate: LTCG on unlisted shares is taxed at a rate of 20%.
- Indexation Benefit: This is a significant advantage for investors. Indexation allows for adjusting the purchase price of the shares for inflation, which can reduce the taxable gain.
- Importance for Investors: Understanding LTCG is crucial, especially for High Net-worth Individuals (HNIs) and retail investors, as it impacts their investment strategy and tax planning. Knowing these details helps in making informed investment decisions.
- Calculation: LTCG is calculated by subtracting the indexed cost of acquisition (the purchase price adjusted for inflation) from the sale price of the shares. The profit thus calculated is subject to a 20% tax.
- Applicability: LTCG tax is applicable to profits from the sale of unlisted shares held for more than two years.
- Relevance: This tax is particularly relevant to investors in the unlisted share market, including those considering selling their holdings after a period of more than two years.
-
Applicability of Taxes on CREDO ADVANCED CHEMICALS LTD once it is listed?
When shares initially bought in the unlisted market become listed, the taxation rules change significantly if these shares are sold through a stock exchange. Here's what investors need to know:
Transition to Listed Market Tax Rates: Once unlisted shares are listed on the stock exchange and subsequently sold, the tax rates applicable to listed securities come into effect. This shift means that the favourable tax treatments for listed shares, as per the prevailing tax laws, will apply.
Taxation Based on Holding Period: The crucial factor in determining the type of capital gains tax (Long-term or Short-term) is the holding period of the shares. Importantly, this period is calculated from the original purchase date when the shares were unlisted.
Long-term vs. Short-term Capital Gains: If the shares are sold after being held for more than one year from the date of purchase (including the period when they were unlisted), they are subject to Long-term Capital Gains (LTCG) tax.
Conversely, if sold within one-year, Short-term Capital Gains (STCG) tax rates apply.
Significance for Investors: This information is vital for investors in the unlisted market, as it impacts their tax planning and decision-making process. Understanding these nuances ensures that investors can strategically plan the sale of their shares post-listing to optimize tax implications.
Advice for Investors: It's advisable for investors to keep a record of their purchase dates and monitor the listing dates closely. Additionally, staying updated with the latest tax regulations or consulting with a financial advisor is recommended for accurate tax calculations and compliance. -
How does Altius Investech source CREDO ADVANCED CHEMICALS LTD?
At Altius Investech, our approach to sourcing CREDO ADVANCED CHEMICALS LTD unlisted shares involves a strategic and direct method. Primarily, we acquire these shares from the below key groups:
Employees of the Company: Employee stock option plans (ESOPs) or other compensation packages frequently include shares for firm employees. For a various reasons, such as including portfolio diversification or financial considerations, some of these employees may eventually choose to sell their shares. We engage with these employees, providing them a platform to sell their shares.
Initial Investors: These are the angel or early-stage investors who provided capital to the business in its early stages. These original investors may look to sell all or part of their ownership position in the company as it develops and flourishes. This might be done for various reasons such as in order to maximise their investment, reallocate resources, or make other calculated financial decisions.
Funding rounds and VC funds: Altius Investech sources the shares from private placement rounds in which private companies seek to obtain capital from the market. Through our platform, venture capital funds can liquidate their shares and we receive the inventory from them when they decide to sell a portion of their ownership through block trades.
By establishing connections with these groups, Altius Investech guarantees our clients a steady and dependable supply of CREDO ADVANCED CHEMICALS LTD unlisted shares. This process not only makes it easier for employees and initial investors in liquidating their assets, but it also gives our clients access to shares that aren't often found on the open market. Our platform effectively facilitates a win-win situation for both buyers and sellers. -
How to trust Altius Investech before buying CREDO ADVANCED CHEMICALS LTD from its platform?
Altius Investech stands at being India's fastest growing and leading marketplace for buying and selling unlisted shares. We believe in enabling access to alternative sources of investments at lower entry barriers to private equity investments.
With more than 25 years of experience, Altius Investech has carved a niche in the financial market by serving more than 8000 clients. The incredible journey is further highlighted by the vast number of transactions that Altius Investech has facilitated transactions that have already exceeded 300 crores.
For investors Altius Investech curates investment opportunities in companies at reasonable valuations which are on the verge of an IPO leading to massive value unlocking. Investments are backed by thorough research and sound investment thesis, with a time bound exit plan.
For ESOP Shareholder and existing Investors, we assist them to liquidate their shares even if they are not publicly traded by creating a platform where we find the right buyers and sellers for the best prices.
Altius Investech have been featured in top media news outlets like Economic Times, Financial Express, Money control. Check out about us on these - leading publications (Click on link) Our journey over these years has not just been about numbers; it's been about building trust and reliability.
We at Altius Investech are dedicated to upholding the greatest levels of ethics and transparency, making sure that your investment experience is not only profitable but also safe and reliable.
Press of Credo Advanced Chemicals Unlisted Share
Featured Blogs of Credo Advanced Chemicals Unlisted Share
Annual Report of Credo Advanced Chemicals Unlisted Share
Company Information of Credo Advanced Chemicals Unlisted Share
Featured Companies


